Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
alnylam pharmaceuticals
amgen
arena pharmaceuticals
biotech
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
cholesterol
colorectal cancer
detroit blog main
detroit top stories
eisai
europe blog main
europe top stories
fda
inclisiran
indiana blog main
indiana top stories
lorcaserin
lung cancer
national
new york
obsesity
orexigen therapeutics
pancreatic cancer
pcsk9 inhibitors
praluent
product recalls
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
What
drug
fda
2
×
market
2
×
bringing
cancer
cholesterol
clears
closer
eisai
filing
flags
higher
inched
incidence
lorcaserin
loss
lowering
marketing
medco
medicine
medicines
morning
patients
phase
positive
post
preps
pulls
result
risks
study
tests
took
touting
twice
weight
withdrawing
yearly
Language
unset
Current search:
market
×
" new york top stories "
×
fda
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
